FDA slams vaping company Juul for illegal marketing practices, threatens fines or seizure

By | September 9, 2019

James Monsees, co-founder and chief product officer at JUUL Labs Inc., appears before the House Economic and Consumer Policy Subcommittee which is examining JUUL’s role in the youth nicotine epidemic, on July 25, 2019 in Washington, DC.

Mark Wilson | Getty Images News | Getty Images

Federal health officials slammed vaping company Juul on Monday for illegally advertising its nicotine pods as a safer alternative to cigarettes, threatening to fine or even seize the company’s products if it doesn’t correct its marketing.

The Food and Drug Administration sent a warning letter  to CEO Kevin Burns after reviewing testimony from two days of hearings in the U.S. House on Juul in July. FDA investigators found the company broke the law “by selling or distributing them as modified risk tobacco products without an FDA order in effect that permits such sale or distribution.”

“Regardless of where products like e-cigarettes fall on the continuum of tobacco product risk, the law is clear that, before marketing tobacco products for reduced risk, companies must demonstrate with scientific evidence that their specific product does in fact pose less risk or is less harmful,” Acting FDA Commissioner Ned Sharpless said in a statement.

“JUUL has ignored the law, and very concerningly, has made some of these statements in school to our nation’s youth,” Sharpless said.

FDA rules require a company to receive regulatory approval before marketing any tobacco product as less harmful than cigarettes. Juul’s vaping devices have never been submitted to the FDA for review. The company has 15 days to respond to the agency. 

In a separate letter sent Monday, the FDA additionally requested more information about the company’s marketing practices. Specifically, the agency is looking for any scientific evidence or data that shows whether its use of words like “switch” and “alternative” give people the idea that Juul’s e-cigarettes are less harmful than cigarettes.

Juul spokesman Ted Kwong said the company was “reviewing the letters and will fully cooperate.”

The FDA is “troubled” about Juul’s marketing and outreach efforts, particularly in high schools, Sharpless said. He pointed to testimony from a student who said a Juul representative came into his school touting it as “much safer than cigarettes” and that “FDA was about to come out and say it was 99% safer than cigarettes.”

The agency also took issue with Juul’s latest advertising campaign that targets adult smokers to “make the switch” from cigarettes to Juul’s vaping devices. It features adults sharing their stories of how they stopped smoking thanks to Juul.

The FDA is concerned the advertisements may convey Juul as less harmful than cigarettes, even though the FDA has not validated these claims.

The agency is also looking into Juul’s use of nicotine salts and the concentration of nicotine in its products. Juul says these features make its e-cigarettes satisfying for former smokers. Critics say they quickly addict people to its products.

Juul’s popularity among teens have drawn the ire of politicians and regulators across the U.S. The FDA conducted a surprise inspection of Juul’s San Francisco headquarters last fall, seizing “more than a thousand pages of documents.” The company is also under investigation by several states attorneys generals and, reportedly, the Federal Trade Commission.

Lawsuits from parents with addicted teens have cropped up around the country accusing Juul of targeting minors and misleading consumers. Monday’s warning letter adds even more pressure to the already embattled company.

Rep. Raja Krishnamoorthi, chairman of the subcommittee that looked into Juul’s marketing practices in July, last week accused Juul of breaking the law.

Separately, health officials are investigating a mysterious lung disease tied to vaping that has sickened hundreds and killed five people. They say it’s too early to pinpoint a cause and are urging people to avoid vaping e-cigarettes or THC, the active ingredient in marijuana, until they can figure out what’s making people sick.

Altria, the largest U.S. tobacco company, invested $ 12.8 billion for a 35% stake in Juul late last year. The company’s shares were unchanged Monday.

Health and Science